620 filings
Page 3 of 31
8-K
hs6oaxen3d
30 Nov 21
TG Therapeutics Provides Regulatory Update
7:59am
8-K
35dgb66c5bmo7gu
4 Nov 21
TG Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
7:27am
8-K
tf7v0tc4a2 05
2 Aug 21
TG Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results
7:12am
8-K
hnjs622huywyf47pc 0z
23 Jun 21
Departure of Directors or Certain Officers
12:00am
8-K
995kp6857vxgtaylw9
21 Jun 21
Amendments to Articles of Incorporation or Bylaws
5:29pm
8-K
4eu3 smax
10 May 21
TG Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results
7:23am
DEFA14A
nob8wa
30 Apr 21
Additional proxy soliciting materials
4:03pm
8-K
ewtzknq4yt p0d0st
16 Apr 21
Other Events
7:53am
8-K
wxcwj64 g6
13 Apr 21
Changes in Registrant's Certifying Accountant
4:30pm
8-K
6m9 iimv7jvm2a
2 Mar 21
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2020 Financial Results
7:07am
8-K
2p3nt
8 Feb 21
UKONIQ is approved for adult patients with relapsed or refractory marginal zone lymphoma after at least one prior anti-CD20 based regimen
7:01am
8-K
m5h5udc3e5lj3
16 Dec 20
Entry into a Material Definitive Agreement
4:16pm
424B5
kzr09
16 Dec 20
Prospectus supplement for primary offering
4:11pm
424B5
2tcwd waebebu
14 Dec 20
Prospectus supplement for primary offering
8:09am